B+
Bull case
25%
Probability
Target price
$7.50
Analysis reference price unavailable
Analysis 2026-09-15 · RankAlpha Sentiment Codex
INGN
InogenFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
International revenue growth, double-digit POC unit-volume growth, new-product contribution, improving gross margin, positive operating cash flow, and a debt-free $106.8 million liquidity position provide credible turnaround optionality. Successful Simeox H data and sustained distributor traction could expand the multiple.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Inogen recorded a $3.9 million Q2 GAAP net loss despite positive adjusted EBITDA, so the profitability inflection remains incomplete. [#SEC-8K-2026-08-06]
Momentum
88
Value
36
Sentiment
27
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.75 · Bull $7.50 · Bear $3.00Analysis 2026-09-15; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $12.00
Why
Momentum88 · Δ7d +18.6
Value36 · Δ7d +0.0
Sentiment27 · Δ7d -9.6
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.0.
Contradictions & invalidation
- • Inogen recorded a $3.9 million Q2 GAAP net loss despite positive adjusted EBITDA, so the profitability inflection remains incomplete. [#SEC-8K-2026-08-06]
- • Low analyst coverage and the absence of disclosed post-print estimate or target revisions reduce confidence in valuation signals.
- • The directional prior remains negative: U.S.
Catalyst clock
2026-12-31
Simeox H China study analysis
Lead driver: Value · See fundamentals
Momentum
88
8% active weight
Current posture
7d trendImproving
Δ7d
+18.6
Δ21d
+73.4
Value
36
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
27
45% active weight
Current posture
7d trendSoftening
Δ7d
-9.6
Δ21d
-18.7
Why this grade
Composite grade F. Momentum 88.5 / Value 36.3 / Sentiment 27.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-15. Scenario method
Most likely
B
Base case
40%
Probability
Target price
$4.75
Analysis reference price unavailable
Analysis 2026-09-15 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$3.00
Analysis reference price unavailable
Analysis 2026-09-15 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$188.42M
Beta
1.80
Shares Out
26.54M
P/E (TTM) · Derived
-8.3
P/S (TTM)
0.52
P/FCF (TTM) · Derived
-20.01
Rev YoY
+3.0%
EPS YoY
-7.5%
Gross Margin
+51.7%
Op Margin
-8.4%
Net Debt
-$103.39M
Current Ratio
2.74
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data